AI in Healthcare

The latest on artificial intelligence transforming medicine

News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.

Filtered by: neuroimagingClear filter
clinicalRadiology Business

FDA Clears Imaging AI for Parkinson’s Disease, Reinforcing the Rise of Neuro AI

Radiology Business reports that the FDA has cleared imaging AI for Parkinson’s disease, adding momentum to the growing market for neurologic AI tools. The announcement suggests neuroimaging is becoming one of the most commercially and clinically active frontiers for AI.

FDA clearanceParkinson's diseaseneuroimagingAI diagnostics
clinical

FDA Clears AI-Enabled MRI for Parkinson’s, Raising the Stakes for Neuroimaging

An FDA-approved AI-based MRI diagnostic for Parkinson's signals growing regulatory acceptance for neurological imaging tools that go beyond conventional image interpretation. The clearance could accelerate interest in AI systems that help identify disease earlier or with greater confidence in complex neurodegenerative care.

National Today
Parkinson'sMRIAI
research

Neurophet’s ALZ-NET deal shows imaging AI scaling through research networks, not consumer channels

Neurophet will provide AI imaging tools to ALZ-NET, a move that highlights how neuroimaging AI is advancing through structured research and clinical data networks. The arrangement signals that adoption in Alzheimer’s care may depend less on flashy product launches and more on fitting into evidence-generating infrastructure.

AuntMinnie
NeurophetALZ-NETAlzheimer's disease
industry

Alzheimer’s Network Deal Shows Imaging AI’s Path Through Clinical Infrastructure, Not Consumer Hype

A U.S.-based Alzheimer’s network is adopting Korean imaging AI technology, underscoring how neurodegenerative care is becoming an important deployment setting for medical AI. The move suggests the market is rewarding tools that can plug into real clinical networks and disease programs, not just produce promising standalone performance metrics.

MobiHealthNews
Alzheimer's diseaseneuroimagingimaging AI
clinical

JLK’s FDA Clearance Suggests Stroke AI Is Expanding Beyond Premium Imaging Inputs

JLK has gained FDA 510(k) clearance for an AI stroke detection tool based on non-contrast CT. The clearance is notable because NCCT is widely available, potentially broadening access to AI-assisted stroke triage beyond centers equipped with more advanced imaging workflows.

koreabiomed.com
strokeFDA 510(k)non-contrast CT

How this works

Discover

An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.

Structure

The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.

Publish

Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.